• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Aripiprazole for the management of olanzapine-induced weight gain.

作者信息

Englisch S, Weinbrenner A, Inta D, Zink M

出版信息

Pharmacopsychiatry. 2009 Jul;42(4):166-7. doi: 10.1055/s-0029-1202262. Epub 2009 Jul 7.

DOI:10.1055/s-0029-1202262
PMID:19585397
Abstract
摘要

相似文献

1
Aripiprazole for the management of olanzapine-induced weight gain.
Pharmacopsychiatry. 2009 Jul;42(4):166-7. doi: 10.1055/s-0029-1202262. Epub 2009 Jul 7.
2
A comparison of weight change during treatment with olanzapine or aripiprazole: results from a randomized, double-blind study.奥氮平或阿立哌唑治疗期间体重变化的比较：一项随机双盲研究的结果
J Clin Psychiatry. 2004;65 Suppl 18:47-56.
3
Aripiprazole improves metabolic adversity in olanzapine-treated schizophrenic patients.阿立哌唑可改善接受奥氮平治疗的精神分裂症患者的代谢不良状况。
J Clin Psychopharmacol. 2007 Oct;27(5):516-7. doi: 10.1097/JCP.0b013e31814fb9a3.
4
Predictive value of early changes in triglycerides and weight for longer-term changes in metabolic measures during olanzapine, ziprasidone or aripiprazole treatment for schizophrenia and schizoaffective disorder post hoc analyses of 3 randomized, controlled clinical trials.奥氮平、齐拉西酮或阿立哌唑治疗精神分裂症和分裂情感障碍的 3 项随机对照临床试验事后分析：早期甘油三酯和体重变化对代谢指标长期变化的预测价值。
J Clin Psychopharmacol. 2010 Dec;30(6):656-60. doi: 10.1097/jcp.0b013e3181faf670.
5
What is the mechanism for aripiprazole's effect on reducing olanzapine-associated obesity?阿立哌唑减轻奥氮平所致肥胖的作用机制是什么？
J Clin Psychopharmacol. 2010 Aug;30(4):480-1. doi: 10.1097/JCP.0b013e3181e74555.
6
Aripiprazole added to overweight and obese olanzapine-treated schizophrenia patients.阿立哌唑添加到接受奥氮平治疗的超重和肥胖精神分裂症患者中。
J Clin Psychopharmacol. 2009 Apr;29(2):165-9. doi: 10.1097/JCP.0b013e31819a8dbe.
7
A double-blind, randomized comparative study of aripiprazole and olanzapine in patients with schizophrenia.阿立哌唑与奥氮平治疗精神分裂症患者的双盲、随机对照研究。
Biol Psychiatry. 2009 Mar 15;65(6):510-7. doi: 10.1016/j.biopsych.2008.07.033. Epub 2008 Nov 4.
8
Aripiprazole-related body-weight gain and nutritional counseling.阿立哌唑相关的体重增加与营养咨询
J Neuropsychiatry Clin Neurosci. 2011 Spring;23(2):E44-5. doi: 10.1176/jnp.23.2.jnpe44.
9
Olanzapine versus aripiprazole for the treatment of agitation in acutely ill patients with schizophrenia.奥氮平与阿立哌唑治疗急性病精神分裂症患者激越症状的比较
J Clin Psychopharmacol. 2008 Dec;28(6):601-7. doi: 10.1097/JCP.0b013e31818aaf6c.
10
Worsened agitation and confusion in schizophrenia subsequent to high-dose aripiprazole.高剂量阿立哌唑治疗后精神分裂症患者的激越和混乱加重
J Neuropsychiatry Clin Neurosci. 2007 Fall;19(4):481-2. doi: 10.1176/jnp.2007.19.4.481.

引用本文的文献

1
The Impact of Adjunctive Aripiprazole on Olanzapine-Induced Metabolic Adverse Effects in Patients With Schizophrenia: A Systematic Review.阿立哌唑辅助治疗对精神分裂症患者奥氮平所致代谢不良反应的影响：一项系统评价
Neuropsychopharmacol Rep. 2025 Sep;45(3):e70046. doi: 10.1002/npr2.70046.
2
Effects of chronic oral treatment with aripiprazole on the expression of NMDA receptor subunits and binding sites in rat brain.阿立哌唑慢性口服治疗对大鼠脑内 NMDA 受体亚单位和结合位点表达的影响。
Psychopharmacology (Berl). 2011 Sep;217(1):127-42. doi: 10.1007/s00213-011-2262-z. Epub 2011 Apr 12.